Pocket Guides

Cardiopulmonary and Kidney Disease in Sickle Cell Disease: Screening and Management

Cardiopulmonary and Kidney Disease in Sickle Cell Disease: Screening and Management

This pocket guide includes key recommendations from the American Society of Hematology upcoming 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease, available soon in Blood Advances.  This guide will ship after publication of the guideline in late 2019.

Note: to order larger quantities please send a detailed request to quality@hematology.org.

Purchase Options List Price Members Price
Print $0.00 $0.00

Venous Thromboembolism (VTE) in the Context of Pregnancy

Venous Thromboembolism (VTE) in the Context of Pregnancy

This pocket guide includes key recommendations from the American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy, available in Blood Advances.

Note: to order larger quantities please send a detailed request to quality@hematology.org.

Purchase Options List Price Members Price
Print $0.00 $0.00

Management of Anticoagulation Therapy

Management of Anticoagulation Therapy

New for 2019, this pocket guide includes key recommendations from the American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy, published in Blood Advances.

Note: to order larger quantities please send a detailed request to quality@hematology.org.

Purchase Options List Price Members Price
Print $0.00 $0.00

Initial Diagnostic Work-Up of Acute Leukemia

Initial Diagnostic Work-Up of Acute Leukemia

Presented by ASH and the College of American Pathology (CAP) in 2017, adapted from Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology. Archives of Pathology & Laboratory Medicine. 2017.
Note: To order larger quantities please send a detailed request to quality@hematology.org.

Purchase Options List Price Members Price
Print $0.00 $0.00

Monoclonal Gammopathy of Undetermined Significance

Monoclonal Gammopathy of Undetermined Significance

Presented by ASH in 2016, adapted in part from Monoclonal gammpathy of undetermined signficance (MGUS) and smoldering (asymptomatic) multiple myeloma: International Myeloma Working Group consensus perspective risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121-1127.

Purchase Options List Price Members Price
Print $0.00 $0.00
1 of 3